Medicine and Dentistry
Human Immunodeficiency Virus
70%
Gastrostomy
53%
Global Disease Burden
52%
Diseases
42%
Drug Resistance
37%
Percutaneous Endoscopic Gastrostomy
27%
Enteric Feeding
26%
Prevalence
23%
Polyethylene Glycol
20%
Systematic Review
18%
Fibrosis
17%
Life Expectancy
16%
Transferrin
16%
Infection
16%
Mortality Rate
14%
Malignant Neoplasm
14%
Body Mass Index
13%
Resistance Mutation
13%
Health Care
12%
Head and Neck Cancer
12%
Genetic Variability
11%
Electron Microscopy
11%
COVID-19
11%
Disability Adjusted Life Years
11%
Nonnucleoside Reverse Transcriptase Inhibitor
11%
Maturity Onset Diabetes of the Young
10%
Health Care Cost
10%
Intestinal Failure
10%
Observational Study
10%
Public Health
10%
Human Immunodeficiency Virus 1
10%
Plummer-Vinson Syndrome
10%
Microscopy
9%
Periodontitis
9%
Cross Sectional Study
9%
Intensive Care Unit
9%
Reverse-Transcriptase Inhibitor
9%
Antiretroviral Therapy
9%
Periodontal Disease
8%
Nutritional Support
8%
Upper Gastrointestinal Bleeding
8%
Nutritional Status
8%
Mental Capacity
8%
Integrase
8%
Nutrition Assessment
8%
Industrial Noise
8%
Behavioral Change
8%
Nutrition
8%
Health System
8%
Transmission Electron Microscopy
7%
Diabetes Mellitus
7%
Morphology
7%
Bone Turnover
7%
Fibromyalgia
7%
Hydrocortisone
7%
In Vitro
7%
Scanning Electron Microscopy
6%
Retrospective Study
6%
Diarrhea
6%
Refeeding Syndrome
6%
Human Immunodeficiency Virus 2
6%
Respiratory Tract Infection
6%
Antiinfective Agent
5%
HIV/AIDS
5%
Randomized Controlled Trial
5%
Short Bowel Syndrome
5%
Gastroenterology
5%
Low and Middle Income Countries
5%
Endoscopy
5%
Next Generation Sequencing
5%
Anti-Inflammatory Drug
5%
Non Communicable Disease
5%
Meta-Analysis
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Antibiotics
5%
Fistula
5%
Nutritional Intervention
5%
Proteinase Inhibitor
5%
Endoscopic Ultrasound
5%
Rilpivirine
5%
Coronary Artery
5%
Mycobacterium Tuberculosis
5%
Soft Contact Lens
5%
Amyotrophic Lateral Sclerosis
5%
Arthritis
5%
Left Ventricle
5%
Right Ventricle
5%
Interventricular Septum
5%
Interleukin 6
5%
Stomach Lesion
5%
Highly Active Antiretroviral Therapy
5%
Parotid Gland
5%
Geographic Mapping
5%
Cardiac Fibrosis
5%
Demography
5%
Microbiome
5%
Refeeding
5%
Medicine
5%
Wound Healing
5%
Chronic Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
78%
Drug Resistance
38%
Diseases
35%
Global Disease Burden
30%
Prevalence
22%
Infection
21%
Transferrin
20%
Antiinfective Agent
20%
Polyethylene Glycol
18%
Antimicrobial Agent
17%
Fibrosis
14%
Nonnucleoside Reverse Transcriptase Inhibitor
14%
Pharmacokinetics
14%
Olanzapine
13%
Wistar Rat
13%
RNA Directed DNA Polymerase Inhibitor
12%
Head and Neck Cancer
12%
Anti-Human Immunodeficiency Virus
12%
Bioequivalence
12%
Drug Release
12%
Dysphagia
12%
Diabetes Mellitus
11%
Community Pharmacy
10%
Randomized Controlled Trial
10%
Human Immunodeficiency Virus 1
10%
Non Insulin Dependent Diabetes Mellitus
10%
Integrase
9%
Nanoparticle
9%
Antibiotics
9%
Wound
8%
Dental Caries
8%
Dosage Forms
8%
Observational Study
8%
Cytotoxicity
8%
Proteinase
8%
Lactam
7%
Efavirenz
7%
Dendrimer
7%
Adhesive Agent
7%
Wound Healing
7%
Rilpivirine
7%
Hepatitis B Virus
7%
Staphylococcus Aureus
6%
Cohort Study
6%
Koji
6%
Antioxidant
6%
Hepatitis C
6%
Biocompatibility
6%
Scanning Electron Microscopy
6%
Human Immunodeficiency Virus 2
6%
Table Salt
6%
Trace Element
6%
Integrase Inhibitor
6%
Side Effect
6%
Proteinase Inhibitor
5%
Antioxidant Capacity
5%
Antimicrobial Resistance
5%
Dolutegravir
5%
Clinical Trial
5%
Plasma Protein
5%
Comorbidity
5%
Human Immunodeficiency Virus Fusion Inhibitor
5%
Serum Albumin
5%
Mycobacterium Tuberculosis
5%
Protein Calorie Malnutrition
5%
Microparticle
5%
Pentapeptide
5%
Prostaglandin H
5%
Drug Carrier
5%
Paracetamol
5%
Hepatitis C Virus
5%
Non Small Cell Lung Cancer
5%
Pyrrole Derivative
5%
Acetonylacetone
5%
Synthetase
5%
Cisplatin
5%
Thalidomide
5%
Embryopathy
5%
Hepatitis B
5%
Raltegravir
5%
Fusion Inhibitor
5%
Adansonia
5%
Heart Muscle Fibrosis
5%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus
99%
Human Immunodeficiency Virus 2
33%
Drug Resistance
28%
Viral Load
28%
Genetic Variability
20%
Blood Plasma
19%
Virus
19%
Cladistics
18%
Dynamics
17%
Neutralizing Antibody
17%
Prevalence
14%
Antibody Response
13%
Glycoprotein
13%
Foot
12%
Antimicrobial Resistance
10%
Antibodies
10%
CD4
10%
Klebsiella pneumoniae
10%
Biofilm
9%
T-Helper Cell
9%
Peptides
9%
Candida
8%
Viremia
8%
Integrase
8%
Phylogeny
8%
Reverse Transcriptase
7%
Antimicrobial Activity
7%
Mycobacterium Tuberculosis
7%
Viral Replication
6%
Infectious Agent
6%
Staphylococcus Aureus
6%
Cytokine
6%
Microorganism
6%
Antimicrobial Agent
6%
CXCR4
6%
HIV/AIDS
5%
Cytotoxicity
5%
Minimum Inhibitory Concentration
5%
Urinary Tract
5%
Population Structure
5%
Binding Antibody
5%
Epitope
5%
Evolution
5%
Glucose Blood Level
5%
DNA Repair
5%
Next Generation Sequencing
5%
Disease Burden
5%
Tumor Necrosis Factor Alpha
5%
Lineages
5%
NS5A
5%
Hepatitis C Virus
5%
Proteus mirabilis
5%
Kidney Transplantation
5%
NS5B
5%